Peritoneal Dialysis
PD is the Future For Many Patients with End-Stage Renal Disease
Improving Access to PD Therapy and Raising the Quality of Care
Since pioneering peritoneal dialysis in 1960, Baxter has been committed to providing ESRD patients with this life-saving therapy. PD enables patients undergoing dialysis to maintain their lifestyle and independence while offering potentially better clinical outcomes and substantially lower costs--a win-win for patients, providers and healthcare systems alike. Baxter, through its partnership with the nephrology community, is committed to improving access to PD therapy, raising the quality of care helping to achieve better outcomes for ESRD patients. Today, we offer the market’s most comprehensive PD portfolio, including the world’s only renal remote patient management system.
Our ambition is to make PD the preferred initial choice of dialysis therapy through smarter patient-centric solutions, helping you offer your patients the best possible care for chronic kidney disease.
Peritoneal Dialysis Facts & Figures
12%
of dialysis patients are on PD today1
1960
Baxter introduces the world’s first PD solution
20%
The cost of PD is approximately 20% lower than that of HD2
The Benefits of Remote Patient Management
Remote patient management - wherein patients’ clinical data is digitally collected and transmitted to his or her hospital or clinic for
monitoring and analysis - has been shown to have trends indicating
fewer hospitalizations, provide improved access to care and lower utilization of healthcare resources3-6.
Important Safety Information
For safe and proper use of products mentioned herein, please refer to the appropriate Operators Manual or Instructions for Use.